vs

Side-by-side financial comparison of CG Oncology, Inc. (CGON) and DeFi Development Corp. (DFDV). Click either name above to swap in a different company.

DeFi Development Corp. is the larger business by last-quarter revenue ($4.6M vs $2.3M, roughly 2.0× CG Oncology, Inc.). DeFi Development Corp. runs the higher net margin — 1211.4% vs -1779.0%, a 2990.4% gap on every dollar of revenue. On growth, DeFi Development Corp. posted the faster year-over-year revenue change (647.2% vs 409.2%).

CG Oncology, Inc. is a clinical-stage biotechnology company focused on developing innovative targeted immunotherapies for urological cancers including non-muscle invasive bladder cancer. It primarily operates in the U.S. market, advancing pipeline candidates to address unmet medical needs for patients with limited treatment options.

Automotive Design and Development Ltd (ADD) was an English company responsible for the creation of the futuristic-looking Nova kit car. It was based in Southampton from 1971 to 1973 after which it moved to Accrington, Lancashire until 1975. ADD failed and the rights to the Nova were bought by Nova Cars in Mirfield, West Yorkshire in 1978, which continued until 1990. A low volume production run was made by Nova Developments in Cornwall in the 1990s and the company was sold to India-based Aerot...

CGON vs DFDV — Head-to-Head

Bigger by revenue
DFDV
DFDV
2.0× larger
DFDV
$4.6M
$2.3M
CGON
Growing faster (revenue YoY)
DFDV
DFDV
+238.0% gap
DFDV
647.2%
409.2%
CGON
Higher net margin
DFDV
DFDV
2990.4% more per $
DFDV
1211.4%
-1779.0%
CGON

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CGON
CGON
DFDV
DFDV
Revenue
$2.3M
$4.6M
Net Profit
$-41.3M
$56.0M
Gross Margin
98.1%
Operating Margin
-2097.3%
Net Margin
-1779.0%
1211.4%
Revenue YoY
409.2%
647.2%
Net Profit YoY
-29.9%
11995.1%
EPS (diluted)
$-0.52
$1.95

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CGON
CGON
DFDV
DFDV
Q4 25
$2.3M
Q3 25
$1.7M
$4.6M
Q2 25
$0
$2.0M
Q1 25
$287.2K
Q4 24
$456.0K
$628.9K
Q3 24
$619.0K
Q2 24
$441.0K
Q1 24
$529.0K
$411.1K
Net Profit
CGON
CGON
DFDV
DFDV
Q4 25
$-41.3M
Q3 25
$-43.8M
$56.0M
Q2 25
$-41.4M
$15.4M
Q1 25
$-778.0K
Q4 24
$-31.8M
$-487.0K
Q3 24
$-471.0K
Q2 24
$-805.0K
Q1 24
$-16.9M
$-964.0K
Gross Margin
CGON
CGON
DFDV
DFDV
Q4 25
Q3 25
98.1%
Q2 25
98.6%
Q1 25
Q4 24
98.8%
Q3 24
98.7%
Q2 24
98.2%
Q1 24
97.9%
Operating Margin
CGON
CGON
DFDV
DFDV
Q4 25
-2097.3%
Q3 25
-3069.0%
Q2 25
Q1 25
-307.5%
Q4 24
-8344.1%
-107.9%
Q3 24
-73.3%
Q2 24
-193.2%
Q1 24
-4247.4%
-247.7%
Net Margin
CGON
CGON
DFDV
DFDV
Q4 25
-1779.0%
Q3 25
-2629.5%
1211.4%
Q2 25
777.0%
Q1 25
-270.9%
Q4 24
-6973.7%
-77.4%
Q3 24
-76.1%
Q2 24
-182.5%
Q1 24
-3200.8%
-234.5%
EPS (diluted)
CGON
CGON
DFDV
DFDV
Q4 25
$-0.52
Q3 25
$-0.57
$1.95
Q2 25
$-0.54
$0.84
Q1 25
$-0.55
Q4 24
$-0.47
$0.55
Q3 24
$-0.05
Q2 24
$-0.08
Q1 24
$-0.36
$-0.70

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CGON
CGON
DFDV
DFDV
Cash + ST InvestmentsLiquidity on hand
$742.2M
$1.4M
Total DebtLower is stronger
$131.4M
Stockholders' EquityBook value
$752.6M
$243.8M
Total Assets
$791.6M
$480.0M
Debt / EquityLower = less leverage
0.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CGON
CGON
DFDV
DFDV
Q4 25
$742.2M
Q3 25
$680.3M
$1.4M
Q2 25
$661.1M
$595.0K
Q1 25
$2.2M
Q4 24
$742.0M
$2.8M
Q3 24
$2.8M
Q2 24
$3.2M
Q1 24
$566.5M
$3.9M
Total Debt
CGON
CGON
DFDV
DFDV
Q4 25
Q3 25
$131.4M
Q2 25
$21.2M
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CGON
CGON
DFDV
DFDV
Q4 25
$752.6M
Q3 25
$687.6M
$243.8M
Q2 25
$670.4M
$79.6M
Q1 25
$2.8M
Q4 24
$733.4M
$3.5M
Q3 24
$4.0M
Q2 24
$4.3M
Q1 24
$568.9M
$5.0M
Total Assets
CGON
CGON
DFDV
DFDV
Q4 25
$791.6M
Q3 25
$729.9M
$480.0M
Q2 25
$701.4M
$107.2M
Q1 25
$4.2M
Q4 24
$754.8M
$4.4M
Q3 24
$4.5M
Q2 24
$4.8M
Q1 24
$579.1M
$5.5M
Debt / Equity
CGON
CGON
DFDV
DFDV
Q4 25
Q3 25
0.54×
Q2 25
0.27×
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CGON
CGON
DFDV
DFDV
Operating Cash FlowLast quarter
$-36.2M
$-5.0M
Free Cash FlowOCF − Capex
$-36.2M
FCF MarginFCF / Revenue
-1560.0%
Capex IntensityCapex / Revenue
0.3%
0.0%
Cash ConversionOCF / Net Profit
-0.09×
TTM Free Cash FlowTrailing 4 quarters
$-124.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CGON
CGON
DFDV
DFDV
Q4 25
$-36.2M
Q3 25
$-38.9M
$-5.0M
Q2 25
$-28.0M
$-1.3M
Q1 25
$-785.6K
Q4 24
$-20.7M
$-2.4M
Q3 24
$-412.0K
Q2 24
$-680.8K
Q1 24
$-26.0M
$-1.1M
Free Cash Flow
CGON
CGON
DFDV
DFDV
Q4 25
$-36.2M
Q3 25
$-39.0M
Q2 25
$-28.0M
Q1 25
Q4 24
$-20.9M
$-2.4M
Q3 24
Q2 24
$-687.4K
Q1 24
$-26.0M
$-1.2M
FCF Margin
CGON
CGON
DFDV
DFDV
Q4 25
-1560.0%
Q3 25
-2340.4%
Q2 25
Q1 25
Q4 24
-4577.0%
-388.2%
Q3 24
Q2 24
-155.9%
Q1 24
-4919.5%
-280.3%
Capex Intensity
CGON
CGON
DFDV
DFDV
Q4 25
0.3%
Q3 25
5.8%
0.0%
Q2 25
Q1 25
Q4 24
45.8%
3.7%
Q3 24
0.0%
Q2 24
1.5%
Q1 24
2.3%
1.6%
Cash Conversion
CGON
CGON
DFDV
DFDV
Q4 25
Q3 25
-0.09×
Q2 25
-0.08×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CGON
CGON

Segment breakdown not available.

DFDV
DFDV

Digital Asset Treasury$3.8M82%
Other$831.0K18%

Related Comparisons